APA (7th ed.) Citation

Zhang, Q., Shen, K., Song, C., Ouyang, Q., Liu, Z., Liu, Q., . . . Shao, Z. Abemaciclib combined with endocrine therapy as adjuvant treatment for hormone-receptor-positive, HER2−, high-risk early breast cancer: 5-year Chinese population analysis of the phase III randomized monarchE study. SAGE Publishing.

Chicago Style (17th ed.) Citation

Zhang, Qingyuan, et al. Abemaciclib Combined with Endocrine Therapy as Adjuvant Treatment for Hormone-receptor-positive, HER2−, High-risk Early Breast Cancer: 5-year Chinese Population Analysis of the Phase III Randomized MonarchE Study. SAGE Publishing.

MLA (9th ed.) Citation

Zhang, Qingyuan, et al. Abemaciclib Combined with Endocrine Therapy as Adjuvant Treatment for Hormone-receptor-positive, HER2−, High-risk Early Breast Cancer: 5-year Chinese Population Analysis of the Phase III Randomized MonarchE Study. SAGE Publishing.